Literature DB >> 23942804

Human papilloma virus lesions of the oral cavity: healing and relapse after treatment with 810-980 nm diode laser.

Francesca Angiero1, Alberto Buccianti, Luisa Parma, Rolando Crippa.   

Abstract

This study evaluated the therapeutic efficacy of laser therapy in treating oral human papilloma virus (HPV) lesions. In particular, mode of action, healing, postoperative patient compliance, visual numeric scale (VNS) pain index, and recurrence were analyzed. During 2001-2012, in 170 patients (80 women and 90 men), 174 intraoral and lip HPV lesions were detected and excised by diode laser of different wavelengths (810-980 nm), with an average power of 2.1 W, in continuous wave mode, using 300 to 320 μm optical fibers. In most cases (95.4%), complete healing occurred in the first 30 days. There were no adverse effects and all patients were carefully followed up until complete healing occurred, documenting any complications. There was only one recurrence, which was later treated successfully; the mean VNS pain score was below one. In treating HPV lesions, the diode laser is not only a valuable tool for their eradication but especially it reduces relapses, thanks to the characteristics of the laser light.

Entities:  

Mesh:

Year:  2013        PMID: 23942804     DOI: 10.1007/s10103-013-1401-7

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  25 in total

Review 1.  The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus.

Authors:  C C R Ragin; F Modugno; S M Gollin
Journal:  J Dent Res       Date:  2007-02       Impact factor: 6.116

2.  Diode laser (808 nm) applied to oral soft tissue lesions: a retrospective study to assess histopathological diagnosis and evaluate physical damage.

Authors:  Francesca Angiero; Luisa Parma; Rolando Crippa; Stefano Benedicenti
Journal:  Lasers Med Sci       Date:  2011-03-09       Impact factor: 3.161

Review 3.  Papillomavirus infections--a major cause of human cancers.

Authors:  H zur Hausen
Journal:  Biochim Biophys Acta       Date:  1996-10-09

4.  Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations.

Authors:  Scott E Strome; Athanasia Savva; Anthony E Brissett; Bobbie S Gostout; Jean Lewis; Amy C Clayton; Renee McGovern; Amy L Weaver; David Persing; Jan L Kasperbauer
Journal:  Clin Cancer Res       Date:  2002-04       Impact factor: 12.531

5.  Frequency and role of HPV in the progression of epithelial dysplasia to oral cancer.

Authors:  Francesca Angiero; Luisa Benerini Gatta; Rossella Seramondi; Angiola Berenzi; Anna Benetti; Sarah Magistro; Paolo Ordesi; Piergiovanni Grigolato; Enrico Dessy
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

Review 6.  The epidemiology of human papillomavirus infections.

Authors:  Janet G Baseman; Laura A Koutsky
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

7.  Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain.

Authors:  San Keller; Carla M Bann; Sheri L Dodd; Jeff Schein; Tito R Mendoza; Charles S Cleeland
Journal:  Clin J Pain       Date:  2004 Sep-Oct       Impact factor: 3.442

8.  Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis.

Authors:  K Syrjänen; S Syrjänen; M Lamberg; S Pyrhönen; J Nuutinen
Journal:  Int J Oral Surg       Date:  1983-12

Review 9.  Pain assessment: global use of the Brief Pain Inventory.

Authors:  C S Cleeland; K M Ryan
Journal:  Ann Acad Med Singapore       Date:  1994-03       Impact factor: 2.473

10.  Validation of the Brief Pain Inventory for chronic nonmalignant pain.

Authors:  Gabriel Tan; Mark P Jensen; John I Thornby; Bilal F Shanti
Journal:  J Pain       Date:  2004-03       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.